Know Cancer

or
forgot password


N/A
18 Years
80 Years
Not Enrolling
Both
Hepatocellular Carcinoma

Thank you

Trial Information


Inclusion Criteria:



- advanced HCC for systemic treatment

Exclusion Criteria:

- HCC only localized in liver,

- Other liver disease (e.g. metastases and benign lesions)

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Prospective

Outcome Measure:

Measure of extent and intensity (standardized uptake value - SUV) of disease demonstrated on PET/CT images before and after treatment.

Outcome Description:

On each PET/CT study diseased tumor activity in the liver and extra-hepatic tissue will be localized and measured on the CT part of the scan (at least two maximal length values), and on the PET part of the scan SUV max value will be calculated by the machine software. Visual appreciation will also be noted.

Outcome Time Frame:

12 weeks: PET/CT performed before treatment and every 4 weeks, after end of each treatment twice

Authority:

Israel: Ministry of Health

Study ID:

0022-11-HMO

NCT ID:

NCT01322477

Start Date:

Completion Date:

Related Keywords:

  • Hepatocellular Carcinoma
  • Identification of treatment efficacy in patients with advanced HCC by PET/CT F18-FDG
  • Carcinoma
  • Carcinoma, Hepatocellular

Name

Location